Clinical trials - Press Releases

Date	Title	Company
21-Dec-2021	Almirall: Lebrikizumab demonstrated significant skin improvement and itch relief when combined with topical corticosteroids in people with atopic dermatitis in third Phase 3 study	Almirall
21-Dec-2021	IACT LMC Manna Research Merges with True North Clinical Research, Boosting the Network’s Central Nervous System Disorder Capabilities	IACT LMC Manna Research
20-Dec-2021	Advancing AI Drug Discovery in Clinical Trials at SMi’s 3rd Annual AI in Drug Discovery Conference	SMi Group
20-Dec-2021	SMi’s 10th Annual Pharmaceutical Microbiology UK Conference - A Virtual Conference with Online Access Only	SMi Group
15-Dec-2021	Panthera leads the way in the UK with specialist research sites for NASH and NAFLD studies	Panthera Biopartners
15-Dec-2021	Hearing loss company Acousia Therapeutics to receive CTA for first-in-man clinical study of ACOU085	Acousia Therapeutics GmbH
15-Dec-2021	YESCARTA® (AXICABTAGENE CILOLEUCEL) ZUMA-12 STUDY DEMONSTRATES 78% COMPLETE RESPONSE RATE AS PART OF FIRST-LINE TREATMENT IN NEWLY DIAGNOSED HIGH-RISK LARGE B CELL LYMPHOMA	Kite, a Gilead Company
15-Dec-2021	4D pharma announces positive topline results from Part A of Phase I/II trial of MRx-4DP0004 for the treatment of asthma	4D pharma
15-Dec-2021	Positive Phase 3 Dupixent® (dupilumab) data in children 6 months to 5 years with moderate-to-severe atopic dermatitis featured in RAD 2021 late-breaking session	Sanofi
14-Dec-2021	Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in cardiac surgery associated acute kidney injury	Vifor Pharma and Angion
14-Dec-2021	iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology Annual Meeting and TIGIT Therapies Digital Summit 2021	iTeos Therapeutics
14-Dec-2021	IDDI Becomes a Medidata Rave EDC Partner	IDDI and Medidata
10-Dec-2021	uniQure and CSL Behring Announce Primary Endpoint Achieved in HOPE-B Pivotal Trial of Etranacogene Dezaparvovec Gene Therapy in Patients with Hemophilia B	uniQure and CSL Behring
10-Dec-2021	IDDI celebrates its 30th anniversary this year	IDDI
09-Dec-2021	4D pharma presents microbiome analyses from Phase II clinical trial of Blautix(R) for IBS-C and IBS-D at Gastro 2021	4D pharma
09-Dec-2021	HUTCHMED Completes Planned Enrollment of FRESCO-2, a Global Phase III Trial of Fruquintinib in Metastatic Colorectal Cancer	HUTCHMED (China) Limited
09-Dec-2021	Vaccitech reports promising interim efficacy analysis in Phase 1b/2a clinical study in chronic HBV	Vaccitech
07-Dec-2021	Co-chairs Philip Hewitt and Stefan Pryzyborski, invitation to join SMi’s 5th Annual 3D Cell Culture Conference	SMi Group
07-Dec-2021	Vaccitech reports promising interim efficacy analysis in Phase 1b/2a clinical study in chronic HBV	Vaccitech plc
06-Dec-2021	Six Key Presentations at SMi's Inaugural Robotics & Automation in Pharma Conference	SMi Group